For the “IL6-JAK-STAT3 signaling” and “Neutrophil degranulation”, there might have been additional differences in the magnitude of these processes early since these pathways were also relatively up- and down-regulated, respectively, at D1 in COVID-19 patients compared to non-COVID-19 sepsis patients (Figure 3B). This evidence concerns the gene STAT3 and COVID-19.